Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Lunn

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|October 31, 2018
Advances in POEMS treatment and the need to define standardised outcome measuresStephen Keddie, Shirley D'Sa, Michael P Lunn
Biomarkers in Medicine|August 25, 2012
Clinical use of cerebrospinal fluid biomarkers in Alzheimer's diseaseHenrik Zetterberg, Michael P Lunn, Sanna-Kaisa Herukka
Movement Disorders Clinical Practice|March 26, 2024
Infections and Stiff-Person Spectrum DisordersShermyn Neo, Michael P Lunn, Kailash P Bhatia
Journal of the Peripheral Nervous System : JPNS|June 27, 2015
Outcome measures in neuromuscular disease: is the world still flat?Michael P Lunn, Peter Y K Van den Bergh
British Journal of Haematology|August 7, 2022
Evidence-based medical treatment of POEMS syndromeJahanzaib Khwaja, Shirley D'Sa, Michael P Lunn, et al.
British Journal of Haematology|June 20, 2019
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?Oliver Tomkins, Stephen Keddie, Michael P Lunn, et al.
Journal of the Peripheral Nervous System : JPNS|August 27, 2015
Future needs in peripheral neuropathy outcome measuresPeter Y K Van den Bergh, Michael P Lunn
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2023
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve diseaseRoberto Bellanti, Stephen Keddie, Michael P Lunn, et al.
Clinical Neurology and Neurosurgery|November 28, 2012
Cervical transverse myelitis like presentation of cranial dural arteriovenous fistulaUmesh Vivekananda, Michael P Lunn, Stefan Brew, et al.
Muscle & Nerve|May 30, 2013
Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barré syndromeIrena Dujmovic, Michael P Lunn, Mary M Reilly, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|October 31, 2018
Advances in POEMS treatment and the need to define standardised outcome measuresStephen Keddie, Shirley D'Sa, Michael P Lunn
Biomarkers in Medicine|August 25, 2012
Clinical use of cerebrospinal fluid biomarkers in Alzheimer's diseaseHenrik Zetterberg, Michael P Lunn, Sanna-Kaisa Herukka
Movement Disorders Clinical Practice|March 26, 2024
Infections and Stiff-Person Spectrum DisordersShermyn Neo, Michael P Lunn, Kailash P Bhatia
Journal of the Peripheral Nervous System : JPNS|June 27, 2015
Outcome measures in neuromuscular disease: is the world still flat?Michael P Lunn, Peter Y K Van den Bergh
British Journal of Haematology|August 7, 2022
Evidence-based medical treatment of POEMS syndromeJahanzaib Khwaja, Shirley D'Sa, Michael P Lunn, et al.
British Journal of Haematology|June 20, 2019
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?Oliver Tomkins, Stephen Keddie, Michael P Lunn, et al.
Journal of the Peripheral Nervous System : JPNS|August 27, 2015
Future needs in peripheral neuropathy outcome measuresPeter Y K Van den Bergh, Michael P Lunn
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2023
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve diseaseRoberto Bellanti, Stephen Keddie, Michael P Lunn, et al.
Clinical Neurology and Neurosurgery|November 28, 2012
Cervical transverse myelitis like presentation of cranial dural arteriovenous fistulaUmesh Vivekananda, Michael P Lunn, Stefan Brew, et al.
Muscle & Nerve|May 30, 2013
Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barré syndromeIrena Dujmovic, Michael P Lunn, Mary M Reilly, et al.
Pageof 14